Top insider buys: Nov 18 – Nov 24, 2024

The largest open-market purchases company insiders reported on SEC Form 4 between Nov 18 – Nov 24, 2024.

Week 47, 2024

#CompanyWho boughtSharesValueSource
1OSCR

Oscar Health, Inc.

2 officers/directors

Cluster buy

Thrive Partners VII Growth GP, LLC, Joshua Kushner

1,065,834

$17.3M

SEC filings
2ZETA

Zeta Global Holdings Corp.

6 officers/directors

Cluster buy

Robert H. Niehaus, William Landman, Imran Khan, Christopher E. Greiner, Steven H. Gerber, David Steinberg

167,911

$3.2M

SEC filings
3MBIN

Merchants Bancorp

2 officers/directors

Cluster buy

Michael R. Dury, Patrick D. O'Brien

82,700

$2.1M

SEC filings
4AZTA

Azenta, Inc.

3 officers/directors

Cluster buy

John Marotta, William L. Cornog, Martin D. Madaus

31,407

$1.2M

SEC filings
5MPAA

MOTORCAR PARTS OF AMERICA INC

3 officers/directors

Cluster buy

BISON CAPITAL PARTNERS VI, L.P., BISON CAPITAL PARTNERS VI-A, L.P., Douglas B. Trussler

150,000

$1.0M

SEC filings
6WOLF

WOLFSPEED, INC.

4 officers/directors

Cluster buy

Darren R. Jackson, Thomas H. Werner, Stacy J. Smith, Duy Loan T. Le

124,851

$817K

SEC filings
7NOVA

Sunnova Energy International Inc.

2 officers/directors

Cluster buy

Corbin J. Robertson III, Akbar Mohamed

189,717

$692K

SEC filings
8WSC

WillScot Holdings Corp

3 officers/directors

Cluster buy

Gerard E. Holthaus, Timothy D. Boswell, Erik Olsson

15,000

$523K

SEC filings
9SCWO

374Water Inc.

2 officers/directors

Cluster buy

Chris M. Gannon, James Michael Vanderhider

370,000

$463K

SEC filings
10RWAY

Runway Growth Finance Corp.

2 officers/directors

Cluster buy

R. David Spreng, Thomas B. Raterman

41,486

$419K

SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.